ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667909 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667909; 2) Community: the network communities that were significantly associated with the response to NSC 667909; 3) Molecule: the relationships between components within communities and NSC 667909; 4) MDR: the compounds that were significantly associated with the NSC 667909.

NSC Compound Enrichment Correlation
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.00334162892839397 0.27750093
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.00334162892839397 0.20046352
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.00334162892839397 0.12624546
NSC 655305 Null 0.00334162892839397 0.33143555
NSC 659390 Null 0.00334162892839397 0.27746014
NSC 154948 M-AMSA 0.00337662564965909 0.20422478
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.00337662564965909 0.20629504
NSC 18805 .gamma.-Thujaplicine 0.00337662564965909 0.23816108
NSC 300289 Pinafide 0.00337662564965909 0.34816616
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.00337662564965909 0.29867503
Total:172  Current:24    [First] [Prev] [Next] [Last]